Follow-up visits after IUD-insertion: Sense or nonsense? A technology assessment study to analyze the effectiveness of follow-up visits after IUD insertion

Contraception

Volumn 68, Issue 2, 2003, Pages 101-104

  Neuteboom, Karlijn ^a   De Kroon, Cornelis D ^a   Dersjant Roorda, Marianne ^a   Jansen, Frank Willem ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Follow up; IUD; Side effects; Technology assessment

Indexed keywords

ADULT; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTRACEPTIVE DEVICE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; NORMAL HUMAN; PREGNANCY; PROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 0041828456     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(03)00111-2     Document Type: Article

References (19)

1. Centraal Bureau voor de Statistiek. Geboorteregeling naar leeftijd vrouw. CBS 2002. www.cbs.nl. Accessed April 10th 2003.
2. Hamerlynck JV, Knuist M. [Modern intra-uterine contraception: a better option]. Ned Tijdschr Geneeskd 2001;145:1621-4 (article in Dutch).
3. Lidegaard O., Edstrom B., Kreiner S. Oral contraceptives and venous thromboembolism a five-year national case-control study . Contraception. 65:2002;187-196.
4. Vandenbroucke J.P., Rosing J., Bloemenkamp K.W., et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med. 344:2001;1527-1535.
5. Luukkainen T., Toivonen J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception. 52:1995;269-276.
6. Monteiro I., Bahamondes L., Diaz J., Perrotti M., Petta C. Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia a pilot study(1) . Contraception. 65:2002;325-328.
7. Hubacher D., Lara-Ricalde R., Taylor D.J., Guerra-Infante F., Guzman-Rodriguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med. 345:2001;561-567.
8. Lete I., Morales P., De Pablo J.L. Use of intrauterine contraceptive devices in nulliparous women personal experience over a 12-year period . Eur J Contracept Reprod Health Care. 3:1998;190-193.
9. Mishell D.R. Intrauterine devices mechanisms of action, safety, and efficacy . Contraception. 58:(Suppl 3):1998;45S-53S.
10. Stanback J., Grimes D. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis. Contraception. 58:1998;357-360.
11. Petta C.A., Amatya R., Farr G., Chi I. An analysis of the personal reasons for discontinuing IUD use. Contraception. 50:1994;339-347.
12. Rivera R., Chen-Mok M., McMullen S. Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUD. Contraception. 60:1999;155-160.
13. Petta C.A., Faundes D., Pimentel E., Diaz J., Bahamondes L. The use of vaginal ultrasound to identify copper T IUDs at high risk of expulsion. Contraception. 54:1996;287-289.
14. Anteby E., Revel A., Ben Chetrit A., Rosen B., Tadmor O., Yagel S. Intrauterine device failure relation to its location within the uterine cavity . Obstet Gynecol. 81:1993;112-114.
15. Zhang J., Feldblum P.J., Chi I.C., Farr M.G. Risk factors for copper T IUD expulsion an epidemiologic analysis . Contraception. 46:1992;427-433.
16. Kremer J, Haspels AA. Interceptie. In: Kremer J, Haspels AA, eds. Geboortenregeling bij de mens. Lochem: De Tijdstroom, 1984. p. 70-81.
17. Nederlandse Vereniging voor Obstetrie en Gynaecologie. Intra-uteriene anticonceptie. NVOG 2002. www.nvog.nl. Accessed April 10th 2003.
18. The intrauterine device. ACOG technical bulletin number 164, February 1992 (replaces no. 104, May 1987). Int J Gynaecol Obstet 1993;41:189-93.
19. Hidalgo M., Bahamondes L., Perrotti M., Diaz J., Dantas-Monteiro C., Petta C. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception. 65:2002;129-132.